BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 15455371)

  • 1. Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility.
    Cheng TC; Chen ST; Huang CS; Fu YP; Yu JC; Cheng CW; Wu PE; Shen CY
    Int J Cancer; 2005 Jan; 113(3):345-53. PubMed ID: 15455371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.
    Huang CS; Chern HD; Chang KJ; Cheng CW; Hsu SM; Shen CY
    Cancer Res; 1999 Oct; 59(19):4870-5. PubMed ID: 10519398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility.
    Fu YP; Yu JC; Cheng TC; Lou MA; Hsu GC; Wu CY; Chen ST; Wu HS; Wu PE; Shen CY
    Cancer Res; 2003 May; 63(10):2440-6. PubMed ID: 12750264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk.
    Saintot M; Malaveille C; Hautefeuille A; Gerber M
    Int J Cancer; 2003 Nov; 107(4):652-7. PubMed ID: 14520706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effect of GSTM1, GSTT1, and COMT genotypes in individual breast cancer risk.
    Park SK; Yim DS; Yoon KS; Choi IM; Choi JY; Yoo KY; Noh DY; Choe KJ; Ahn SH; Hirvonen A; Kang D
    Breast Cancer Res Treat; 2004 Nov; 88(1):55-62. PubMed ID: 15538046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study.
    Han DF; Zhou X; Hu MB; Xie W; Mao ZF; Chen DE; Liu F; Zheng F
    Chin Med J (Engl); 2005 Sep; 118(18):1507-16. PubMed ID: 16232327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population.
    Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
    Arch Toxicol; 2002 Nov; 76(11):643-9. PubMed ID: 12415427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer risk associated with genotypic polymorphism of the mitosis-regulating gene Aurora-A/STK15/BTAK.
    Lo YL; Yu JC; Chen ST; Yang HC; Fann CS; Mau YC; Shen CY
    Int J Cancer; 2005 Jun; 115(2):276-83. PubMed ID: 15688402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of catechol estrogens metabolism pathway genes and breast cancer risk in Mexican women.
    Martínez-Ramírez OC; Pérez-Morales R; Castro C; Flores-Díaz A; Soto-Cruz KE; Astorga-Ramos A; Gonsebatt ME; Casas L; Valdés-Flores M; Rubio J
    Breast; 2013 Jun; 22(3):335-43. PubMed ID: 23000097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex.
    Hsu HM; Wang HC; Chen ST; Hsu GC; Shen CY; Yu JC
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2024-32. PubMed ID: 17932350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association of polymorphisms in SULT1A1 and UGT1A1 Genes with breast cancer risk and phenotypes in Russian women].
    Shatalova EG; Loginov VI; Braga EA; Kazubskaia TP; Sudomoina MA; Blanchard RL; Favorova OO
    Mol Biol (Mosk); 2006; 40(2):263-70. PubMed ID: 16637266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer risk associated with genotypic polymorphism of the mitotic checkpoint genes: a multigenic study on cancer susceptibility.
    Lo YL; Yu JC; Chen ST; Hsu GC; Mau YC; Yang SL; Wu PE; Shen CY
    Carcinogenesis; 2007 May; 28(5):1079-86. PubMed ID: 17210994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multigenic study on breast cancer risk associated with genetic polymorphisms of ER Alpha, COMT and CYP19 gene in BRCA1/BRCA2 negative Shanghai women with early onset breast cancer or affected relatives.
    Hu Z; Song CG; Lu JS; Luo JM; Shen ZZ; Huang W; Shao ZM
    J Cancer Res Clin Oncol; 2007 Dec; 133(12):969-78. PubMed ID: 17562079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphic catechol-O-methyltransferase gene, duration of estrogen exposure, and breast cancer risk: a nested case-control study in Taiwan.
    Lin WY; Chou YC; Wu MH; Jeng YL; Huang HB; You SL; Chu TY; Chen CJ; Sun CA
    Cancer Detect Prev; 2005; 29(5):427-32. PubMed ID: 16191465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen metabolism genotypes, use of long-term hormone replacement therapy and risk of postmenopausal breast cancer.
    Cerne JZ; Novakovic S; Frkovic-Grazio S; Pohar-Perme M; Stegel V; Gersak K
    Oncol Rep; 2011 Aug; 26(2):479-85. PubMed ID: 21567099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.
    Lavigne JA; Helzlsouer KJ; Huang HY; Strickland PT; Bell DA; Selmin O; Watson MA; Hoffman S; Comstock GW; Yager JD
    Cancer Res; 1997 Dec; 57(24):5493-7. PubMed ID: 9407957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP17, catechol-o-methyltransferase, and glutathione transferase M1 genetic polymorphisms, lifestyle factors, and breast cancer risk in women on Prince Edward Island.
    Cribb AE; Joy Knight M; Guernsey J; Dryer D; Hender K; Shawwa A; Tesch M; Saleh TM
    Breast J; 2011; 17(1):24-31. PubMed ID: 21129090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible risk modification by polymorphisms of estrogen metabolizing genes in familial breast cancer susceptibility in an Indian population.
    Syamala VS; Syamala V; Sheeja VR; Kuttan R; Balakrishnan R; Ankathil R
    Cancer Invest; 2010 Mar; 28(3):304-11. PubMed ID: 19863350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms in human SULT1A1 and UGT1A1 genes associate with breast tumor characteristics: a case-series study.
    Shatalova EG; Walther SE; Favorova OO; Rebbeck TR; Blanchard RL
    Breast Cancer Res; 2005; 7(6):R909-21. PubMed ID: 16280036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catechol-O-methyltransferase polymorphism is not associated with ovarian cancer risk.
    Goodman JE; Lavigne JA; Hengstler JG; Tanner B; Helzlsouer KJ; Yager JD
    Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1373-6. PubMed ID: 11142424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.